Cathleen M. Brdlik, Ph.D. - Publications

Affiliations: 
Yale University, New Haven, CT 
Area:
organic synthesis, pharmacology, molecular biology

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Sarup J, Jin P, Turin L, Bai X, Beryt M, Brdlik C, Higaki JN, Jorgensen B, Lau FW, Lindley P, Liu J, Ni I, Rozzelle J, Kumari R, Watson SA, et al. Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts. Molecular Cancer Therapeutics. 7: 3223-36. PMID 18852126 DOI: 10.1158/1535-7163.Mct-07-2151  0.311
2006 Yeh JR, Ju R, Brdlik CM, Zhang W, Zhang Y, Matyskiela ME, Shotwell JD, Crews CM. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proceedings of the National Academy of Sciences of the United States of America. 103: 10379-84. PMID 16790550 DOI: 10.1073/Pnas.0511313103  0.308
2004 Brdlik CM, Crews CM. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. The Journal of Biological Chemistry. 279: 9475-80. PMID 14676204 DOI: 10.1074/Jbc.M307246200  0.308
Show low-probability matches.